Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer.

about

Rationale for the development of alternative forms of androgen deprivation therapy.Sigma1 Pharmacology in the Context of Cancer.Novel insights into chromosomal conformations in cancer.Cloning the sigma2 receptor: Wandering 40 years to find an identity.

P2860

Q39342369-9AE2A194-B5C5-4D7C-938F-5CC9BD74AFA3 Q39458668-D332BB06-2302-41A7-92AF-9D5DDE28C062 Q47098649-5AF1BF90-A137-48D8-B683-F16B99D1E701 Q47153188-A9FEF563-8CA7-4850-9929-21AD6169C8DF

P2860

Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer.

Item

http://www.wikidata.org/entity/Q38943216

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer.

@en

type

Item

label

Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer.

@en

prefLabel

Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer.

@en

P1476

Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer.

@en

P2093

Blase Kania

http://www.w3.org/2001/XMLSchema#string

Charles G Longen

http://www.w3.org/2001/XMLSchema#string

Christina M Maher

http://www.w3.org/2001/XMLSchema#string

Felix J Kim

http://www.w3.org/2001/XMLSchema#string

Halley M Oyer

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Thomas

http://www.w3.org/2001/XMLSchema#string

Joseph M Salvino

http://www.w3.org/2001/XMLSchema#string

Kelsey N Anderson

http://www.w3.org/2001/XMLSchema#string

Nan Chen

http://www.w3.org/2001/XMLSchema#string

William F Ostrander

http://www.w3.org/2001/XMLSchema#string

P2860

Structural organization of the endoplasmic reticulum.

Purification, molecular cloning, and expression of the mammalian sigma1-binding site

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth

Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival

Targeting the dynamic HSP90 complex in cancer

Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model.

Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer

Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.

Cloning and characterization of a mouse sigma1 receptor.

P304

2439-2452

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-16-1055

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Karen E Knudsen

P577

2017-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28235766

http://www.w3.org/2001/XMLSchema#string

P932

5462524

http://www.w3.org/2001/XMLSchema#string

Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer.

about

P2860

P2860

Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932